ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

SEER Seer Inc

2.04
0.045 (2.26%)
13 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Seer Inc SEER NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.045 2.26% 2.04 17:28:56
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.00 1.99 2.10 1.99 1.995
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
08/5/202415:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202415:15EDGAR2Form 8-K - Current report
08/5/202415:05GLOBESeer Reports First Quarter 2024 Financial Results
08/5/202415:03GLOBESeer Launches New Technology Access Center in Europe to..
23/4/202415:05GLOBESeer to Report First Quarter 2024 Financial Results on May..
06/3/202415:14EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/2/202415:15EDGAR2Form 8-K - Current report
29/2/202415:05GLOBESeer Reports Fourth Quarter and Full Year 2023 Financial..
23/2/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202415:05GLOBESeer to Participate in the TD Cowen 44th Annual Health Care..
07/2/202420:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202407:00GLOBESeer Proteograph™ Enables Unprecedented Genetic Marker..
01/2/202415:05GLOBESeer to Report Fourth Quarter and Full Year 2023 Financial..
03/1/202407:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
22/12/202315:10EDGAR2Form 8-K - Current report
21/12/202315:05GLOBESeer to Present at the J.P. Morgan 42nd Annual Health Care..
17/11/202315:58EDGAR2Form 8-K - Current report
10/11/202308:00GLOBESeer to Present at the Canaccord MedTech, Diagnostics and..
08/11/202308:00GLOBESeer Wins Proteomics Solution of the Year by BioTech..
07/11/202315:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202315:18EDGAR2Form 8-K - Current report
07/11/202315:05GLOBESeer Reports Third Quarter 2023 Financial Results
01/11/202308:00GLOBESeer Announces Addition of Panome Bio to Centers of..
19/10/202315:05GLOBESeer to Report Third Quarter 2023 Financial Results on..
08/9/202315:05GLOBESeer to Participate in Upcoming September Investor..
08/8/202315:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202315:15EDGAR2Form 8-K - Current report
08/8/202315:05GLOBESeer Reports Second Quarter 2023 Financial Results
27/7/202315:05GLOBESeer to Present at the Canaccord Genuity 43rd Annual Growth..
21/7/202315:29EDGAR2Form 8-K - Current report
13/7/202315:05GLOBESeer to Report Second Quarter 2023 Financial Results on..
07/6/202308:00GLOBESeer Collaborates to Make Scalable, Unbiased Proteomics..
01/6/202308:00GLOBESeer Launches the Proteograph XT Assay Kit: Allowing Labs to..

Su Consulta Reciente

Delayed Upgrade Clock